Noul
About Noul
Noul is a South Korea-based healthcare AI company specializing in an AI-based digital microscope platform for blood analysis. Their flagship product, miLab, is designed as a Decentralized Diagnostic Platform, making advanced diagnostics accessible to resource-limited medical facilities, clinics, and local hospitals. The system automates and digitizes the entire diagnostic workflow, from sample preparation to analysis, aiming to deliver high accuracy and speed compared to conventional methods.
For physicians, Noul’s technology offers a robust solution to enhance diagnostic capabilities, particularly in areas with limited laboratory infrastructure. The miLab device is an all-in-one, fully-automated system that integrates computer vision AI, bio-engineering, hardware, and software to process samples and provide AI-driven diagnoses. Noul is actively expanding its diagnostic applications, with current and developing products focusing on critical areas such as malaria diagnosis, general blood analysis, peripheral blood smears, and cervical cancer screening. The company’s overarching mission is to address chronic and systemic healthcare challenges globally by improving medical access to essential diagnostic testing.
Focus Areas
Business Intelligence
| Key Investors | FuturePlay, Korea Investment & Securities |
| Partnerships | Charité University Hospital (Germany), Limbach Group (Germany), Infinite Medical (US), Nihon Kohden Mexico, Biomedica, FIND (Foundation for Innovative New Diagnostics), Swiss Tropical and Public Health Institute, Swiss Malaria Group, National Malaria Control Program (Malawi), Ghana Infectious Disease Center, Center for Health System Strengthening (Ghana), University of Lagos (Nigeria), University of Notre Dame du Lac, Boston Children's Hospital, Columbia University The Earth Institute, PATH, Institut Pasteur Korea, Seoul National University Nano Systems Institute SOFT Foundry, UN Global Compact, Impact Alliance, Seegene Brazil |
| Technology | miLab™ is an all-in-one, fully-automated digital microscopy platform integrating computer vision AI, biotechnology, hardware, and software engineering. It utilizes proprietary solid-state staining (NGSI) technology and on-device AI, enabling operation independent of network connectivity for point-of-care diagnostics. |
| FDA Clearances | 6 cleared products (estimated) |
What Physicians Need to Know
For physicians, Noul's miLabu2122 platform offers significant advantages by enabling faster and more consistent diagnostic decisions due to its full automation and AI analysis, reducing diagnostic delays. Its high accuracy and reliability, even detecting cases missed by traditional microscopy, provide greater confidence in results. The ease of use and minimal training required for the system allow for efficient reallocation of human resources. Crucially, its decentralized, point-of-care capabilities and cloud-independent operation expand access to high-quality diagnostics in various settings, including remote or underserved areas. Physicians can also benefit from comprehensive analysis across malaria, blood disorders, and cervical cancer, with the added flexibility of remote review capabilities. The cost-effectiveness and eco-friendly staining further contribute to its appeal in modern healthcare.
Noul's miLabu2122 platform is designed as an all-in-one diagnostic solution, integrating sample preparation, digital imaging, and AI analysis within a single compact device. While the core platform is self-contained with on-device AI, its digital nature allows for potential integration with existing Electronic Health Record (EHR) systems for streamlined data management and remote review via its software viewer. Noul is actively expanding its market presence through strategic partnerships with laboratory networks and distributors globally, indicating a readiness for broader healthcare ecosystem integration.
Reviews & Opinions
Videos
News, demos, and interviews about Noul.
Videos load interactively. If none appear, search YouTube for Noul →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]